PPT1 Antikörper (N-Term)
Kurzübersicht für PPT1 Antikörper (N-Term) (ABIN7188634)
Target
Alle PPT1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Verwendungszweck
- PPT1 Antibody
-
Kreuzreaktivität
- Maus, Ratte
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from the N-terminal region of Human CLN1.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- PPT1 (Palmitoyl-Protein Thioesterase 1 (PPT1))
-
Andere Bezeichnung
- PPT1
-
Hintergrund
- Ceroid palmitoyl palmitoyl protein thioesterase 1 antibody, CLN1 antibody, EC 3.1.2.22 antibody, INCL antibody, Palmitoyl protein hydrolase 1 antibody, Palmitoyl protein thioesterase 1 antibody, Palmitoyl-protein hydrolase 1 antibody, Palmitoyl-protein thioesterase 1 antibody, PPT antibody, PPT-1 antibody, PPT1 antibody, PPT1_HUMAN antibody
-
UniProt
- P50897
-
Pathways
- SARS-CoV-2 Protein Interaktom
Target
-